Page 4«..3456..1020..»


Category Archives: Hypogonadism

Novel oral testosterone therapy shows liver health benefits – Urology Times


Posted: June 15, 2020 at 1:58 am

A novel lymphatically delivered oral testosterone undecanoate (Tlando) is a fixed-dose, well-tolerated, and effective treatment for hypogonadism with liver health benefits that clearly differentiate it from the potentially hepatotoxic oral methyltestosterone, reported Irwin Goldstein, MD, at the American Urological Association 2020 Virtual Experience. This innovative product has exciting, paradigm-shifting potential for treating men with low testosterone, said Goldstein, director of Sexual Medicine at Alvarado Hospital in San Diego, California, and clinical professor of surgery at the University of California San Diego Continue reading

Posted in Hypogonadism | Comments Off on Novel oral testosterone therapy shows liver health benefits – Urology Times

Male Hypogonadism Therapy Market Business Analysis 2020 by Leading Industrial Source, Statistics, Gross Margin, Upstream Analysis, Downstream Analysis…


Posted: June 15, 2020 at 1:58 am

The global Male Hypogonadism Therapy Market is showing promising signs that can be explored well in the coming days to achieve a notable valuation by the end of 2020. The process would also witness a growth by % CAGR in between 2020 to 2026 Continue reading

Posted in Hypogonadism | Comments Off on Male Hypogonadism Therapy Market Business Analysis 2020 by Leading Industrial Source, Statistics, Gross Margin, Upstream Analysis, Downstream Analysis…

Male Hypogonadism Market Future Growth by In Depth Industry Analysis, Size, Trends and Forecast to 2026 – Cole of Duty


Posted: June 11, 2020 at 10:48 am

New York City, United States The effect of the coronavirus pandemic and the lockdown it activated is unmistakably obvious in budgetary markets. Continue reading

Posted in Hypogonadism | Comments Off on Male Hypogonadism Market Future Growth by In Depth Industry Analysis, Size, Trends and Forecast to 2026 – Cole of Duty

COVID-19 Update: Global Transdermal Testosterone Market is Expected to Grow at a Healthy CAGR with Top players: AbbVie, Teva, Perrigo, Endo…


Posted: June 11, 2020 at 10:48 am

A perfect mix of quantitative & qualitative Transdermal Testosteronemarket information highlighting developments, industry challenges that competitors are facing along with gaps and opportunities available and would trend in Transdermal Testosterone market. The study bridges the historical data from 2014 to 2019 and estimated until 2026. Continue reading

Posted in Hypogonadism | Comments Off on COVID-19 Update: Global Transdermal Testosterone Market is Expected to Grow at a Healthy CAGR with Top players: AbbVie, Teva, Perrigo, Endo…

Male Hypogonadism Therapy Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 – Cole of Duty


Posted: June 8, 2020 at 11:55 am

A new market report by Market Research Intellect on the Male Hypogonadism Therapy Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. Continue reading

Posted in Hypogonadism | Comments Off on Male Hypogonadism Therapy Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 – Cole of Duty

Male Hypogonadism Market to Witness a Healthy YoY Growth during 2017 2026 – Personal Injury Bureau UK


Posted: June 8, 2020 at 11:55 am

A Comprehensive Report on Male Hypogonadism Market by XMR The fact that XploreMR as published serves 350+ clients every day is enough to display our proficiency. We are a globally recognized market research firm with 60+ countries covered under our radar Continue reading

Posted in Hypogonadism | Comments Off on Male Hypogonadism Market to Witness a Healthy YoY Growth during 2017 2026 – Personal Injury Bureau UK

Jacobs School appoints new chair of Obstetrics and Gynecology – UB Now: News and views for UB faculty and staff – University at Buffalo Reporter


Posted: June 8, 2020 at 11:55 am

Sarah L. Berga has been appointed as the new chair of the Department of Obstetrics and Gynecology in the Jacobs School of Medicine and Biomedical Sciences at UB. She will also serve as president of UBMD Obstetrics & Gynecology, and medical director of Obstetrics and Gynecology and Maternal Fetal Medicine Program Development for Kaleida Health Continue reading

Posted in Hypogonadism | Comments Off on Jacobs School appoints new chair of Obstetrics and Gynecology – UB Now: News and views for UB faculty and staff – University at Buffalo Reporter

Transdermal Testosterone Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026| – Jewish Life News


Posted: May 31, 2020 at 9:42 pm

QY Research as of late produced a research report titled, Transdermal Testosterone . The research report speak about the potential development openings that exist in the worldwide market. Continue reading

Posted in Hypogonadism | Comments Off on Transdermal Testosterone Market Growth by Top Companies, Trends by Types and Application, Forecast to 2026| – Jewish Life News

Male Hypogonadism Market Future Aspect Analysis and Current Trends by 2017 to 2025 – 3rd Watch News


Posted: May 24, 2020 at 8:45 am

Global Male Hypogonadism Market: Snapshot Hypogonadism in males refers to a condition in the male body where the testes show a significantly reduced level of functioning than normal. Continue reading

Posted in Hypogonadism | Comments Off on Male Hypogonadism Market Future Aspect Analysis and Current Trends by 2017 to 2025 – 3rd Watch News

Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy – Yahoo Finance


Posted: May 24, 2020 at 8:45 am

RALEIGH, N.C., May 21, 2020 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals announced today that the United States Patent and Trademark Office (USPTO) has issued two key patents related to its lead asset, Kyzatrex*. Kyzatrex is an oral Testosterone Replacement Therapy (TRT) that uses an innovative formulation to improve effectiveness and safety. These allowed claims will provide strong IP protection to December 2030, over 8 years of potential commercial runway Continue reading

Posted in Hypogonadism | Comments Off on Marius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy – Yahoo Finance

Page 4«..3456..1020..»